Article
TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors
21 Feb 2021
Abstract excerpt
OBJECTIVE: Metastatic Leydig cell tumors (LCT) are rare, difficult-to-treat malignancies without known underlying molecular-genetic events. An index case of metastatic LCT showed an LDLR-TERT gene fusion upon routine genetic profiling for detection of therapeutic targets, which was then followed by an investigation into a cohort of additional LCTs. PATIENTS AND METHODS: Twenty-nine LCT (27 male and 2 female...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
